Multaq May Cause Serious Liver Damage
Multaq (dronedarone) hit the market promoted as a prescription drug that could reduce the occurrence of atrial fibrillation and other heart rhythm disorders. On its website, Sanofi Aventis, the manufacturer of Multaq, proclaimed that the drug can work to lower the “chance that you would need to go to the hospital.” But Sanofi conventiently withheld the…